Get access to our best features
Get Started
Subscribe
Israel-Hamas Conflict
Met Gala
Tornado
Donald Trump
US Politics
US Economy
Joe Biden
Baseball
US Social Issues
NBA
US Crime
Mother's Day
Republican Party
Get access to our best features
Get Started
Published 12 days ago

Merck stock rises on sales of its blockbuster cancer drug Keytruda

Summary by Quartz
Merck’s stock jumped 3% to about $130 during Thursday morning trading after the New Jersey-based pharmaceutical company reported higher than expected sales of its blockbuster cancer drug Keytruda.Read more...

0 Articles

All
Left
Center
Right
QuartzQuartz

Merck stock rises on sales of its blockbuster cancer drug Keytruda

Merck’s stock jumped 3% to about $130 during Thursday morning trading after the New Jersey-based pharmaceutical company reported higher than expected sales of its blockbuster cancer drug Keytruda.Read more...

12 days ago·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Stock MarketsStock Markets
MerckMerck
New JerseyNew Jersey
US EconomyUS Economy
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal